NCT02181101 - Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial | Biotech Hunter

Enrollment

3,754

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Breast Neoplasms

Interventions

DRUG

FEC-DocGemzar adjuvant chemotherapy

DRUG

FEC-Doc adjuvant chemotherapy

DRUG

Zoledronic acid i.v. 2 years

DRUG

Zoledronic acid i.v. 5 years

Trial Locations (1)

Klinikum der Universität München, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt, Munich